Gateway Traditional Grant Program supports researchers at institutions worldwide to conduct early-phase cancer treatment trials that center patients and could change the standard of care.
The Joint Society for Integrative Oncology (SIO) Program supports SIO investigators and institutions conducting patient-centered clinical trials to strengthen evidence for integrative cancer care.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.